This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Pluristem Therapeutics Inc
PSTI : NASDAQ : Health Care
$2.72 0.04 | 1.50%
Today's Range: 2.64 - 2.73
Avg. Daily Volume: 144,000
01/26/15 - 12:40 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
PSTI PLURISTEM THERAPEUTICS INC 2.70 189.21 n/m 0.38 -34.55
CYTK CYTOKINETICS INC 7.05 258.09 n/m 49.53 483.88
STML STEMLINE THERAPEUTICS INC 13.22 225.86 n/m 0.29 n/a
THLD THRESHOLD PHARMACEUTICALS 3.52 220.88 n/m 14.25 26.08
GALE GALENA BIOPHARMA INC 1.64 199.19 n/m 7.44 535.98
PLX PROTALIX BIOTHERAPEUTICS INC 2.06 192.97 n/m 14.90 42.71
CBMG CELLULAR BIOMEDICINE GROUP 17.80 177.04 n/m 0.95 889.58
ENZY ENZYMOTEC LTD 7.00 154.80 15.22 54.83 208.84
ATHX ATHERSYS INC 1.98 153.48 n/m 2.31 -39.38
KMDA KAMADA LTD 4.09 147.16 n/m 70.57 52.77
CRIS CURIS INC 1.68 144.49 n/m 9.37 -38.19
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

PSTI Ind Avg S&P 500
n/m 83.11 19.47
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs